Protagenic Therapeutics, Inc.\New (PTIXW) — DEF 14A Filings
All DEF 14A filings from Protagenic Therapeutics, Inc.\New. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Protagenic Therapeutics Seeks Auditor Ratification Amid Going Concern Doubts
— Dec 5, 2025 Risk: high
Protagenic Therapeutics, Inc. (PTIXW) is holding its Annual Meeting of Stockholders on December 31, 2025, virtually, to ratify the appointment of Green Growth C -
Protagenic Therapeutics Files Definitive Proxy Statement
— Mar 10, 2025 Risk: low
Protagenic Therapeutics, Inc. filed its definitive proxy statement on March 10, 2025, for its annual meeting. The filing outlines the company's governance, exec -
Protagenic Therapeutics Files 2025 Proxy Statement
— Jan 3, 2025 Risk: low
Protagenic Therapeutics, Inc. filed a definitive proxy statement on January 3, 2025, for its annual meeting. The filing details the company's governance and exe
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX